PATENT CLAIM ANALYSIS

Application Number: 16246920
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "009100"]

Abstract:
The present invention provides liposomes comprising a lipid bilayer and a polymer-conjugated lipid, wherein said polymer-conjugated lipid is incorporated into said lipid bilayer. The present invention also provides methods of producing the liposomes as well as a method of delivering a nucleic acid to a subject comprising the step of administering said nucleic acid encapsulated in a mixed liposome, a method for performing diagnostic imaging in a subject, comprising the step of administering a diagnostic agent encapsulated in a mixed liposome, and methods for treating, inhibiting, or suppressing a pathological condition in a subject comprising administering to said subject a mixed liposome.

Claim (Index 143):
The method of  claim 140 , wherein said drug is administered orally, intravenously, intranasally, intraocularly, intramuscularly, subcutaneously or topically.

Metadata:
- Claim Count in Document: 79.0
- Percentile: 99.0
- Lexical Diversity: 2.29167
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14115869', '14252084', '14242602', '14765620', '15691130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7474535862221668
- 35 USC 102 Novelty (BERT): 0.5563161620946571
- Combined Prediction Score: 0.7283398438094159
- Mean Citation Score: 285.06999600000006
- Max Citation Score: 460.63895
- Similarity Product: 295.69913446348613

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test